Member Info for jamrock

http://ir.q4europe.com/Tools/newsArticleHTML.aspx?solutionID=3774&customerKey=Staffline&storyID=15507644
Let’s see what’s said at the 2pm presentation
But I see nothing to worry about.Alberts statement was as expected

http://ir.q4europe.com/Tools/newsArticleHTML.aspx?solutionID=3774&customerKey=Staffline&storyID=15507577
Result are what we expected but new contract win is a bonus. Nothing to worry about

At the last investor meeting Albert talked about new contracts that were not in the last results so will be interesting what effect they have on these results or guidance he gives. Providing we don’t get a recession we will be fine. Interesting to see if employers are paying more per hour for the workers hence keeping our margins in check.

I actually think we will show resilience in a unpredictable market however I agree a cautious stance because a world wide slowdown is looking likely. Our BMW contracts etc will be showing dividend. Be nice to the stance on future
Dividends and listen to reasons for no Directors buying. Think we could surprise to the upside though. Don’t forget capital raise was 50p so today may prove cheap. Tomorrow is another day and we’ll all know

Since the results we have been on a downward trend but I personally feel we are poised for
A bounce however a positive RNS would be appreciated. Results were fantastic and we have new products however we’ve sold off. I feel it’s definitely ready for a turnaround. I’m still sticking with my long term strategy and beginning to buy more today however painful it is to watch the fall from 2.5p. Fundamentals are fantastic and the worries surrounding Covid sales must be the cause however the board had to caution against Covid sales because no one can predict rule changes etc. The fact is we are evolving into more than a Covid play and figures regarding Covid are favourable to us.

Results tomorrow and no excitement in Staffline!. Hopefully something positive tomorrow

I think the fact we are able to sell on Amazon could open a nice avenue to to revenue. I still feel the lack of guidance or reference to how sales are going in early launch from website is a reasonable concern. I hope I’m reading too deep but hopefully Amazon will help move things on. Hopefully Covid sales continue as well as new products but I personally feel extremely anxious as regards the lack of communication other than we now selling on Amazon. I’m still believer in the strategy but airing on the side of cation due
to lack of knowing how early sales are going. I know some will say it’s way early to know but beg to differ because early figures would be available however I do accept they may be waiting to see how Amazon sales perform before any update which may also be a wise strategy. It wouldn’t be to difficult to say this to reassure us though!. Anyway let’s all remain supporting and believe in the board who are employed to make decisions and maybe I should wait a few months and not expect too much in the the early months of the new product release and promotions.

Listen I’m just frustrated with the lack of info that could easily have helped the share price which was rising with momentum however don’t be put off because we will Continue the journey because the fundamentals ain’t changed. Penny is still the right person to take us forward. She over seen a massive turnaround and continues to make great calls. That said communication with shareholders is healthy because investors are savvy enough to forward think. Yes it’s early to offer figures on new products and I accept that but a line to reflect how they are currently performing in her opinion would have been well received and took us to a place where MHC should really be. Nearly 10m turnover and positive EBITDA expected is a tremendous achievement so not forget the fundamentals are in tack. The company is cash rich in my eyes and acquisitions would be great to expand even quicker. One year from now I think will be the ones who look at the share price as a missed opportunity because I think we head higher soon enough. MHC is not just a Covid play however the revenue is seriously helpful to the strategy. I will 100% keep buying at these prices but frustrating to see a company like MHC with such a low languishing share price which is unbelievably low. The large share buys is an early indicator that the big boys know the potential in MHC.

https://www.tradingview.com/symbols/LSE-STAF/technicals/

A bit early to say we’ve turned the corner but data does point to a a more positive feeling. This is early so I caution against it because volume is low and this can turn negative quickly. However results due on August 2nd. If this is for really and we keep rising I would argue that 58p-59p would look a fair target. This is subject to us keep pushing up slowly without another sharp sell off in the run up to the results. The 50DMA is what I’m watching and if we cross this and hold it’s positive in my view

Excuse the spellings.

Penny could easily have said the new products are selling in like with expectations or the role out going to plan. I hope I’m wrong but unless we get another RNS I’m convinced she’s either got no positive update or what she said may have had a more negative impact so she’s chose the easy option and say nothing.
I say this because if she needed a capital raise I assure you she would of added something to do with the new products to keep investors interested. Sorry but I feel Penny s as bud the board have done an excellent job and need crediting but miss the moment to reassure and gain respect from shareholders. This to me is unprofessional and demonstrates lack of communication and is insulting shareholders intelligence and certainly not done anything to fill future investors with confidence. If Penny goes on boards like this as many Directors do to get a feel for shareholders opinions I would urge her to address our points. It’s a reasonable request and failure to do so could lead to shareholders value being evaporated. It was a poor update in my view with a clear message of concern and caution for future Covid revenue which appears to be the bulk of revenue. I hope does the correct thing and speaks to fifer reassurance.
The good thing is we are analysing and exchanging opinions dignified which is great because we all have different ways to view the results.
It makes me sad to think I sound negative but I’m not just dissatisfied that penny Missed the opportunity.

HotChip
You know I’m one of MHCs biggest supporters and I’ve backed that up with a large shareholding however I feel I feel Dactions comments are valid. Penny could easily had said something to offer a more positive feel to the new product performance so far so she clearly missed that opportunity. I think we are all willing MHC on because we are all invested. Whilst we know the Covid products are doing well nothing was said regarding new products. I feel a secondary RNS should be released to clear this up to satisfy shareholders in my opinion. I genuinely believe in MHC but investors confidence is key to a company strategy for growth. We have many positive points in the statement but I also feel they are dragging there feet. More dragging on lack of information which is causing a real positive momentum to stall. This however could prove an excellent entry point or top up point but I would of welcomed more information which all shareholders deserve in my opinion. Revenue is fantastic though but long term MHC is branded on a wellness business so information on all products is the very least the company should have provided. They clearly must of realised the markets wouldn’t take a positive view on that point. Anyway I hope they address this point or buy large quantities to show support. Just my opinion but will stay invested and buy more because I do believe in MHC strongly

To me I didn’t hear enough regarding new products etc. No indication on how they were selling or performing and whilst MHC will expand with new products is crystal clear that revenue generated is mostly Generated via Covid products. This is not a bad things as Covid is surging again however I’m keen to know how the new products are doing. I think the lack of info is a missed opportunity and worries me a little because you expect Penny to rave about them if they were flying off the shelf. I’m a large shareholder and revenue etc was fantastic but I need data on new products to 100% be convinced the strategy is working. I do have faith in the team but hope more info is forthcoming to prevent us falling again. Just my opinion but not convinced enough info or data was supplied and my question is why not!.
I hope I’m thinking too deep but lack of data and info on new products is worrying but I hope another RNS follows shortly to address this to generate new investors.

Well we hit 2.5p but failed to hold. Don’t know what to make of that as I would of liked it to hold. The good news is we held above 2p so hopefully after today’s sell off we recover. Like others have said Amazon is great news but curious why nothing in Boots or Lloyds.
Hoping for a swift recovery to keep momentum going.

News imminent any day now. Hopefully it’s helps us push upwards. I think we are willing the share on and I noticed a big buyer keeps coming in every time it falls. Who is it!!!. Anyway our time is coming and hopefully 2.5p will break and that’s the confirmation I need to be reassured the rise is for real this time. I think Penny and the board are building something special in MHC and the markets may catch on if the news is good.

Mercia clearly see value in MHC and good results and positive news on existing products could easily see a rerate. I just wonder if MHC will use the profits to fund more takeover targets. Not many companies bringing in revenue like MHC in these markets so will be interesting to see what the strategy is.
I’m just glad we are back above 2p and consolidating and looking ready to push upwards. Just hope for all long term holders who invested at higher prices we finally get news we’ve been waiting for.
I would expect us get something this week based on the last update.

London Market
The buyers keep coming back in so hopefully we hold above 2p. I think we’re all waiting for information and hopefully we won’t be disappointed. It would be great if we could push North of 2.5p. I think we are consolidating for the next move. I also think all the emphasis is on the new products quite rightly so however I believe Covid is coming back at a rapid pace. This all bodes well for MHC and once again providing we stay above 2p I’m happy until the next big push upwards. The big buys demonstrates someone else also thinks so. Someone is trying to accumulate at these prices. I’m hoping to see 5p this year but positive news is crucial. I also believe MHC may use the profits to takeover smaller companies and grow faster however I see no reason why investors can’t be rewarded with a small dividend if profits exceed expectations. This would certainly open the eyes of institutional investors.

Someone is clearly starting to buy in big amounts. The price still not moving up. Strange!

Spread has narrowed 2.21 to sell and 2,2 to buy. This the tightest I’ve seen it

http://ir.q4europe.com/Tools/newsArticleHTML.aspx?solutionID=3774&customerKey=Staffline&storyID=15487479
We will all know the results shortly. Hopefully Albert will be able to answer questions why he ain’t bought any shares while taking huge performance bonuses